LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Gout patients study in a new report 'Global Gout Epidemiology and Patient Flow Analysis - 2017'.
Download the full report: https://www.reportbuyer.com/product/3895286The report provides insights into Gout epidemiology, Gout diagnosed patients, and Gout treatment rate for top seven pharmaceutical markets. The study measures key
indicators such as prevalence of Gout derived from epidemiological analysis, percentage of patients diagnosed with Gout, and percentage of patients treated with a therapy. The study helps executives estimate Gout market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Gout prevalence, Gout diagnosis rate, and Gout treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources. Key Features of the Report:
- Gout Patient Flow - Gout Prevalence - Gout Diagnosed Patients - Gout Treated PatientsDownload the full report: https://www.reportbuyer.com/product/3895286
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: email@example.com
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/global-gout-epidemiology-and-patient-flow-analysis---2017-300558386.html